CD19-BAFF CAR-T Cells Therapy for Patients With Relapsed / Refractory B-cell ALL and B-cell NHL

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Acute Lymphoblastic Leukemia,B-Cell · Non-hodgkin Lymphoma,B Cell

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The first affiliated hospital of medical college of zhejiang university, Hangzhou, Zhejiang, China
Contact: Study coordinator (He Huang, MD) · hehuangyu@126.com · 86-13605714822
Contact: Study coordinator (Yongxian Hu, MD) · huyongxian2000@aliyun.com · +8615957162012

Study leads

He Huang, MD
Principal Investigator
Zhejiang University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of CTA101 UCAR-T Cell Injection in Patients With Relapsed or Refractory CD19+ B-line Hematological Malignancy

Acute Lymphoblastic Leukemia · Non-hodgkin Lymphoma

Abroad (travel likely)RecruitingEARLY_PHASE1

Hangzhou, China

A Study of Humanized CD19 CAR-T Cells Therapy for Patients With Relapsed and/or Refractory B-cell ALL and B-cell NHL

Acute Lymphoblastic Leukemia · Non-hodgkin Lymphoma,B Cell

Abroad (travel likely)RecruitingEARLY_PHASE1

Hangzhou, China

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

Acute Leukemia · Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE2

Seattle, United States

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia · Chronic Lymphocytic Leukemia

Abroad (travel likely)RecruitingPHASE2

Duarte, United States · Atlanta, United States